Cargando…
Immune Checkpoint Blockade Therapy May Be a Feasible Option for Primary Pulmonary Lymphoepithelioma-like Carcinoma
Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare subtype of non-small cell lung cancer (NSCLC) for which there is currently no recognized treatment. Recently, favorable immune checkpoint blockade responses have been observed in PPLELC. This study aimed to review the effects of t...
Autores principales: | Wu, Zuohong, Xian, Xinghong, Wang, Ke, Cheng, Deyun, Li, Weimin, Chen, Bojiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110193/ https://www.ncbi.nlm.nih.gov/pubmed/33981599 http://dx.doi.org/10.3389/fonc.2021.626566 |
Ejemplares similares
-
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses
por: Chen, Bojiang, et al.
Publicado: (2021) -
Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma
por: Liu, Fei, et al.
Publicado: (2023) -
Lymphoepithelioma-like Carcinoma (LELC) of the Prostate
por: Eisa, Waleed, et al.
Publicado: (2016) -
Primary pulmonary lymphoepithelioma-like carcinoma: a rare type of lung cancer with a favorable outcome in comparison to squamous carcinoma
por: Chen, Bojiang, et al.
Publicado: (2019) -
About a case of lymphoepithelioma-like carcinoma of the bladder
por: Chaker, Kays, et al.
Publicado: (2018)